(Q67902809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

The effects of Provera on chemotherapy of uterine cancer cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

The effects of provera on chemotherapy of uterine cancer cell lines (English)

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

5 December 2022

1 reference

cervix uterine cancer

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

5 December 2022

author name string

H. N. Nguyen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

B. U. Sevin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

H. E. Averette

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

J. Perras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

R. Ramos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

M. Penalver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

D. Donato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832652

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832652

5 December 2022

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:0090825891903397?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

https://api.elsevier.com/content/article/PII:0090825891903397?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

5 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

165-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

Cisplatin chemotherapy for disseminated endometrial cancer

19 September 2019

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Gestagens and endometrial carcinoma

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

The treatment of advanced endometrial cancer with hydroxyprogesterone caproate

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate

5 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Performance of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome in contaminated samples of amniotic fluid.

5 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing

5 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescence

5 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Synergistic effects of cis-platinum and cytosine arabinoside on ovarian carcinoma cell lines, demonstrated by dual-parameter flow cytometry

5 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma

5 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium

5 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0090-8258(91)90339-7

5 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832652%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference